# Grifols

Type: Company (GRFS)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/grifols
Canonical HTML page: https://gethealthbrief.com/entity/grifols

## Timeline

- **2031**: Market Peak — Projected valuation of $25.15 billion reached through global capacity expansion.
- **2026**: Current Milestone — Market valuation hits significant mid-term growth targets as supply meets latent demand.
- **2024**: Infrastructure Investment — Major fractionators announce multi-billion dollar investments in automated collection centers.
- **2022**: Supply Recovery — Plasma collection volumes begin to stabilize following pandemic-era disruptions.

## Recent coverage (1 stories)

### Immunoglobulin Market Set for $25.15B Valuation by 2031 Amid Plasma Surge
2026-02-20 13:51:17 · Sentiment: Positive · Impact: 6/10 · Sources: 2

The global immunoglobulin market is projected to reach $25.15 billion by 2031, fueled by a significant expansion in plasma collection infrastructure. This growth reflects rising clinical demand for antibody therapies and improved supply chain efficiencies across major pharmaceutical hubs.
Full story: https://gethealthbrief.com/story/immunoglobulin-market-growth-2031-plasma-expansion

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.